What is IncontiLase ?

IncontiLase™ is a non-surgical laser therapy for the treatment and for prevention of future occurrence of mild and moderate stress urinary incontinence, based on non-ablative laser initiated stimulation of development of new collagen fibres that cause shrinking and tightening of vaginal mucosa tissue and collagen-rich endopelvic fascia, and subsequently result in greater support to the bladder and urethra reducing hypermobility of urethra thus eliminating Stress urine leaks.

The indications for IncontiLase therapy are mild and moderate stress- and mixed-urinary incontinence (SUI). World-wide clinical studies show that it is an efficient, easy-to-perform and safe procedure.

How does IncontiLase™ work?

The Touch uses non-ablative laser with proprietary “Smooth-mode” technology that thermally affects the vaginal tissue, stimulating collagen remodeling and the synthesis of new collagen fibers in the region of the vestibule and urethral orifice, as well as in the area along the anterior vaginal wall. It must be noted that the Smooth-mode is the only approved technique as it does not cause tissue injury or scarring and fibrosis.

Unique advantages of IntcontiLase™ for our clients

A major advantage of IncontiLase is that the procedure is incisionless and virtually painless, with no ablation, cutting, bleeding, or sutures. Recovery is extremely quick without need for the use of analgesics or antibiotics.

Usually two to three sessions are recommended to alleviate mild or even moderate stress urinary incontinence. No special pre-op preparation or post-op precautions are necessary. Patients can immediately return to their normal everyday activities. Studies confirm that IncontiLase is an effective, safe and comfortable treatment option for symptom relief in patients with mild and moderate SUI.

Exceptional clinical results

• Scientific results from clinical studies show excellent improvement for mild and moderate stress urinary incontinence.
• Almost 70% of patients are dry after 120 days
• 120 days after IncontiLase treatment 94% of patients reported improvement and 68% of all patients claimed to be free of SUI symptoms
• Improvement of SUI in all measured parameters
• No adverse events noted in any of the studies